Cannara Biotech to release fiscal 2025 results Nov. 24

Executive Summary

• Cannara Biotech Inc. will release its financial results for the fiscal fourth quarter and fiscal year ended August 31, 2025, on November 24, 2025.
• An earnings webcast will be hosted by CEO Zohar Krivorot and CFO Nicholas Sosiak on the same day at 11 a.m. ET.
• The company announced the passing of long-serving board member Jack M. Kay, who joined the board in 2019.

Key Details

• Financial Release Date: November 24, 2025, at 7 a.m. ET.
• Reporting Period: Fiscal Q4 2025 and Fiscal Year 2025 (ended August 31, 2025).
• Webcast Details:
  • Date: Monday, November 24, 2025.
  • Time: 11 a.m. ET.
  • Format: Prepared remarks followed by a Q&A session.
  • Registration: Via the company's website event section.
  • Questions: Investors encouraged to submit in advance to [email protected]; priority given to email submissions.
• Board Update:
  • Announcement of the passing of Jack M. Kay.
  • Mr. Kay served on the board since 2019.
  • Professional Background: 35 years at Apotex Inc. (CEO, COO, President, Vice-Chairman); Chairman of Helix Biopharma Corp. and Cangene Corp.; Director of Barr Pharmaceuticals Inc.; Chairman of Humber River Regional Hospital.

Notable Quotes

• "Cannara would also like to announce with great sadness the passing of Jack M. Kay, a long-serving and highly respected member of the board of directors."
• "The corporation extends its deepest condolences to Mr. Kay's family and expresses its sincere gratitude for his years of service and meaningful contributions to Cannara."